{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P11362",
      "entity_text" : "FGFR1",
      "features" : [ {
        "to_base" : "K",
        "site" : 656,
        "feature_type" : "mutation",
        "evidence" : "K656E"
      } ],
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0568" ],
      "Organ" : [ "uberon:UBERON:0000105" ]
    }
  },
  "verbose_text" : "Because we used a constitutive active form of FGFR1, we cannot exclude that, upon FGFR1 amplification as seen in a subset of human SCLC, FGFR signaling is less pronounced and therefore not associated with some of the adverse effects of FGFR1 K656E expression we observed here.",
  "reading_complete" : "2020-08-08T17:44:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T17:41:09Z",
  "trigger" : "expression",
  "evidence" : [ "FGFR1 K656E  expression" ],
  "pmc_id" : "7090386",
  "score" : 0
}